These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 8163669

  • 41. Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance.
    Castellani LW, Nguyen CN, Charugundla S, Weinstein MM, Doan CX, Blaner WS, Wongsiriroj N, Lusis AJ.
    J Biol Chem; 2008 Apr 25; 283(17):11633-44. PubMed ID: 18160395
    [Abstract] [Full Text] [Related]

  • 42. Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice.
    Baroukh N, Bauge E, Akiyama J, Chang J, Afzal V, Fruchart JC, Rubin EM, Fruchart-Najib J, Pennacchio LA.
    Arterioscler Thromb Vasc Biol; 2004 Jul 25; 24(7):1297-302. PubMed ID: 15117734
    [Abstract] [Full Text] [Related]

  • 43. A novel type hypertriglyceridemia observed in FLS mice.
    Takahashi M, Saibara T, Nemoto Y, Ono M, Akisawa N, Iwasaki S, Toda K, Ogawa Y, Wakatsuki A, Inagaki S, Onishi S.
    Lipids; 2003 Jul 25; 38(7):687-92. PubMed ID: 14506831
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.
    Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL.
    Science; 1990 Aug 17; 249(4970):790-3. PubMed ID: 2167514
    [Abstract] [Full Text] [Related]

  • 46. Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome.
    Kashyap ML, Srivastava LS, Hynd BA, Brady D, Perisutti G, Glueck CJ, Gartside PS.
    Atherosclerosis; 1980 Jan 17; 35(1):29-40. PubMed ID: 7370086
    [No Abstract] [Full Text] [Related]

  • 47. Functional analyses of human apolipoprotein CII by site-directed mutagenesis: identification of residues important for activation of lipoprotein lipase.
    Shen Y, Lookene A, Nilsson S, Olivecrona G.
    J Biol Chem; 2002 Feb 08; 277(6):4334-42. PubMed ID: 11719505
    [Abstract] [Full Text] [Related]

  • 48. C-terminal domain of apolipoprotein CII as both activator and competitive inhibitor of lipoprotein lipase.
    Cheng Q, Blackett P, Jackson KW, McConathy WJ, Wang CS.
    Biochem J; 1990 Jul 15; 269(2):403-7. PubMed ID: 2386483
    [Abstract] [Full Text] [Related]

  • 49. Enhanced lipoprotein lipase secretion from human monocyte-derived macrophages caused by hypertriglyceridemic very low density lipoproteins.
    Ishibashi S, Mori N, Murase T, Shimano H, Gotohda T, Kawakami M, Akanuma Y, Takaku F, Yamada N.
    Arteriosclerosis; 1989 Jul 15; 9(5):650-5. PubMed ID: 2783078
    [Abstract] [Full Text] [Related]

  • 50. Hypertriglyceridemia in nephrotic rats is due to a clearance defect of plasma triglyceride: overproduction of triglyceride-rich lipoprotein is not an obligatory factor.
    Yoshino G, Hirano T, Nagata K, Maeda E, Naka Y, Murata Y, Kazumi T, Kasuga M.
    J Lipid Res; 1993 Jun 15; 34(6):875-84. PubMed ID: 8354953
    [Abstract] [Full Text] [Related]

  • 51. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.
    Altomonte J, Cong L, Harbaran S, Richter A, Xu J, Meseck M, Dong HH.
    J Clin Invest; 2004 Nov 15; 114(10):1493-503. PubMed ID: 15546000
    [Abstract] [Full Text] [Related]

  • 52. Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.
    Sakurai T, Sakurai A, Vaisman BL, Amar MJ, Liu C, Gordon SM, Drake SK, Pryor M, Sampson ML, Yang L, Freeman LA, Remaley AT.
    J Pharmacol Exp Ther; 2016 Feb 15; 356(2):341-53. PubMed ID: 26574515
    [Abstract] [Full Text] [Related]

  • 53. Existence of lipoprotein lipase in rat brain microvessels.
    Shirai K, Saito Y, Yoshida S, Matsuoka N.
    Tohoku J Exp Med; 1986 Aug 15; 149(4):449-50. PubMed ID: 3775767
    [Abstract] [Full Text] [Related]

  • 54. Apolipoprotein CII-Padova (Tyr37-->stop) as a cause of chylomicronaemia in an Italian kindred from Siculiana.
    Tuzgöl S, Bijvoet SM, Bruin T, Kastelein JJ, Hayden MR.
    J Med Genet; 1994 Aug 15; 31(8):622-6. PubMed ID: 7815420
    [Abstract] [Full Text] [Related]

  • 55. Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice.
    van Diepen JA, Wong MC, Guigas B, Bos J, Stienstra R, Hodson L, Shoelson SE, Berbée JF, Rensen PC, Romijn JA, Havekes LM, Voshol PJ.
    J Lipid Res; 2011 May 15; 52(5):942-50. PubMed ID: 21357939
    [Abstract] [Full Text] [Related]

  • 56. Cytochrome P450 1A1 promoter as a genetic switch for the regulatable and physiological expression of a plasma protein in transgenic mice.
    Smith JD, Wong E, Ginsberg M.
    Proc Natl Acad Sci U S A; 1995 Dec 05; 92(25):11926-30. PubMed ID: 8524876
    [Abstract] [Full Text] [Related]

  • 57. Demonstration of apolipoprotein CII in guinea pigs. Functional characteristics, cDNA sequence, and tissue expression.
    Andersson Y, Thelander L, Bengtsson-Olivecrona G.
    J Biol Chem; 1991 Mar 05; 266(7):4074-80. PubMed ID: 1999402
    [Abstract] [Full Text] [Related]

  • 58. [Quantitation of human serum apolipoprotein CII by radial immunodiffusion assay].
    Fan P, Liu BW, Fu MD, Zhang RJ.
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Dec 05; 20(4):352-5. PubMed ID: 2517121
    [Abstract] [Full Text] [Related]

  • 59. On the mechanisms by which human apolipoprotein A-II gene variability relates to hypertriglyceridemia.
    Julve J, Blanco-Vaca F, Carles Escolà-Gil J.
    Circulation; 2002 Apr 30; 105(17):e129; author reply e129. PubMed ID: 11980699
    [No Abstract] [Full Text] [Related]

  • 60. The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism.
    Lee JH, Giannikopoulos P, Duncan SA, Wang J, Johansen CT, Brown JD, Plutzky J, Hegele RA, Glimcher LH, Lee AH.
    Nat Med; 2011 Jun 12; 17(7):812-5. PubMed ID: 21666694
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.